Sertraline

Back to search

Molecule Structure

Scientific Name

Sertraline

Description of the Drug

Sertraline is a selective serotonin reuptake inhibitor (SSRI) indicated to treat major depressive disorder, social anxiety disorder and many other psychiatric conditions.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01104

Brand Name(s)

Not Available

Company Owner(s)

Viatris Specialty Llc, Invagen Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Torrent Pharmaceuticals Ltd, Chartwell Molecular Holdings Llc, Fosun Pharma Usa Inc, Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc, Anda Repository Llc, Accord Healthcare Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Serotonin transporter SINGLE PROTEIN INHIBITOR CHEMBL228

Unichem Links

SureChEMBL SCHEMBL28701
PharmGKB PA451333
Human Metabolome Database HMDB0005010
DrugBank DB01104
PubChem: Thomson Pharma 14923174 14776364
PubChem 68617
Mcule MCULE-4360779618
LINCS LSM-3843
Nikkaji J33.072H
PDBe SRE
BindingDB 50028094 79021
EPA CompTox Dashboard DTXSID6023577
DrugCentral 2436
Brenda 10052 145083 145997
ChemicalBook CB5157644 CB12630479 CB52652538
Guide to Pharmacology 4798
rxnorm SERTRALINE HYDROCHLORIDE ZOLOFT SERTRALINE
KEGG Ligand C07246
ChEBI 9123
ZINC ZINC000001853550